Literature DB >> 16702752

Systemic cholesterol embolization syndrome associated with myeloperoxidase-anti-neutrophil cytoplasmic antibody.

Toshiro Sugimoto1, Yoshikata Morita, Yukiyo Yokomaku, Keiji Isshiki, Keizo Kanasaki, Yutaka Eguchi, Daisuke Koya, Atsunori Kashiwagi.   

Abstract

A 75-year-old man was transferred to our department because of development of severe renal impairment after coronary artery bypass grafting. Hemodialysis was initiated for postsurgical oliguria and lung congestion. On transfer, he showed systemic purpura rashes and diffuse blue mottlings on his toes with marked eosinophilia and an elevated level of C-reactive protein. Cutaneous biopsy revealed cholesterol crystal embolism and leukocytoclastic vasculitis in dermal arterioles. Myeloperoxidase-anti-neutrophil cytoplasmic antibody titer was increased. Upon oral corticosteroid therapy following intravenous pulse steroid therapy, the purpura dramatically diminished, renal function improved, and hemodialysis was discontinued. Active treatment with corticosteroids may be effective for cholesterol embolization syndrome, particularly when clinical and laboratory manifestations mimic systemic vasculitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16702752     DOI: 10.2169/internalmedicine.45.1553

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  Systemic cholesterol embolization syndrome in a patient positive for anti-cardiolipin antibody.

Authors:  Motonobu Nakamura; Yoshiki Tokura
Journal:  Dermatoendocrinol       Date:  2010-04

2.  Anti-neutrophil cytoplasmic antibodies in cholesterol embolism: A case report and literature review.

Authors:  Jun Zhang; Heng-Yuan Zhang; Shi-Zhi Chen; Ji-Yi Huang
Journal:  Exp Ther Med       Date:  2016-05-17       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.